scholarly article | Q13442814 |
P50 | author | Urszula Oleksiewicz | Q59555936 |
Angeliki Malliri | Q61274025 | ||
John K. Field | Q42754256 | ||
Anastasia Filia | Q56435798 | ||
George Xinarianos | Q56444885 | ||
P2093 | author name string | Triantafillos Liloglou | |
John R Gosney | |||
Alexandros Daskalos | |||
George Nikolaidis | |||
P2860 | cites work | The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors | Q22010018 |
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development | Q22010765 | ||
ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain | Q24303631 | ||
UHRF1 plays a role in maintaining DNA methylation in mammalian cells | Q24336152 | ||
Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth | Q24534791 | ||
DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA | Q24645346 | ||
ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells | Q24651299 | ||
Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing | Q24652350 | ||
Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1 | Q27651995 | ||
Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism | Q27651997 | ||
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells | Q28212826 | ||
Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer | Q28240062 | ||
The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines | Q74421009 | ||
The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle | Q28260808 | ||
Cloning and mapping of Np95 gene which encodes a novel nuclear protein associated with cell proliferation | Q28588925 | ||
The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA | Q28589108 | ||
Epigenetics in cancer | Q29547853 | ||
Epigenetics in cancer | Q29617139 | ||
The DNA methyltransferases of mammals | Q29617317 | ||
Methylation-induced repression--belts, braces, and chromatin | Q29617487 | ||
Linking DNA methylation and histone modification: patterns and paradigms | Q29617801 | ||
The Rac activator STEF (Tiam2) regulates cell migration by microtubule-mediated focal adhesion disassembly | Q30494105 | ||
DNA methylation, methyltransferases, and cancer | Q30993657 | ||
DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value | Q33251855 | ||
Rethinking how DNA methylation patterns are maintained | Q33763852 | ||
Meiotic and epigenetic defects in Dnmt3L-knockout mouse spermatogenesis. | Q33927698 | ||
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells | Q34166536 | ||
Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors | Q34573834 | ||
Epigenetic gene silencing in cancer: the DNA hypermethylome | Q34646556 | ||
Establishment and maintenance of DNA methylation patterns in mammals. | Q36434829 | ||
Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer. | Q36667464 | ||
Proteins that bind methylated DNA and human cancer: reading the wrong words | Q36740636 | ||
The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? | Q36894164 | ||
Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors | Q37036306 | ||
p16 Promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia | Q37245583 | ||
Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity, and mode of interaction with DNA. | Q37348708 | ||
Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements | Q39695383 | ||
UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer | Q39770055 | ||
DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis | Q39847607 | ||
TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays | Q39850044 | ||
Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner. | Q40050705 | ||
Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway | Q40427781 | ||
RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells | Q40559173 | ||
Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing | Q41834670 | ||
Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. | Q53559080 | ||
Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer. | Q53591404 | ||
DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma. | Q53622156 | ||
Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. | Q54569187 | ||
Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas | Q57890923 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1027-1037 | |
P577 | publication date | 2010-11-08 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer | |
P478 | volume | 117 |
Q36506865 | A cell cycle-dependent BRCA1-UHRF1 cascade regulates DNA double-strand break repair pathway choice |
Q41133927 | Accumulation of genomic alterations in 2p16, 9q33.1 and 19p13 in lung tumours of asbestos-exposed patients |
Q37279405 | Amplicon Resequencing Identified Parental Mosaicism for Approximately 10% of "de novo" SCN1A Mutations in Children with Dravet Syndrome |
Q35848254 | An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer |
Q35662659 | Analysis of UHRF1 expression in human ovarian cancer tissues and its regulation in cancer cell growth |
Q40751381 | Analysis of the UHRF1 expression in serum and tissue for gastric cancer detection |
Q39449331 | Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1. |
Q28394629 | Associations of DNMT3B -149C>T and -2437T>A polymorphisms and lung cancer risk in Chinese population |
Q35165791 | Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway. |
Q37718344 | CDDO-Me reveals USP7 as a novel target in ovarian cancer cells |
Q38756270 | Clinicopathological analysis of UHRF1 expression in medulloblastoma tissues and its regulation on tumor cell proliferation |
Q57210488 | Comparative Proteomics of Dying and Surviving Cancer Cells Improves the Identification of Drug Targets and Sheds Light on Cell Life/Death Decisions |
Q93065274 | DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications |
Q42585685 | Depletion of Uhrf1 inhibits chromosomal DNA replication in Xenopus egg extracts |
Q89879844 | Design and Construction of a Focused DNA-Encoded Library for Multivalent Chromatin Reader Proteins |
Q39252224 | Diagnostic and prognostic value of plasma and tissue ubiquitin-like, containing PHD and RING finger domains 1 in breast cancer patients |
Q34989248 | Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties |
Q37705867 | Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma |
Q60912066 | Epigenetic mechanism and target therapy of UHRF1 protein complex in malignancies |
Q36346904 | Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention |
Q38313414 | Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma |
Q42877755 | L-methionase: a therapeutic enzyme to treat malignancies |
Q55009932 | LINE-1 hypomethylation is inversely correlated with UHRF1 overexpression in gastric cancer. |
Q55633259 | Long noncoding RNA UPAT promoted cell proliferation via increasing UHRF1 expression in non-small cell lung cancer. |
Q54977612 | Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL. |
Q26742136 | Modifiers and Readers of DNA Modifications and Their Impact on Genome Structure, Expression, and Stability in Disease |
Q37588387 | Molecular gene signature and prognosis of non-small cell lung cancer |
Q54244821 | Overexpression of UHRF1 is significantly associated with poor prognosis in laryngeal squamous cell carcinoma. |
Q24315922 | PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression |
Q36386895 | Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer |
Q36189555 | RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation |
Q28073257 | Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer |
Q36781882 | TPL2 kinase is a suppressor of lung carcinogenesis |
Q47130735 | Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy |
Q55129550 | Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development. |
Q37937460 | The Roles of the Methyl-CpG Binding Proteins in Cancer |
Q39304639 | The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer. |
Q24297944 | The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein |
Q60044999 | The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism |
Q55445741 | Thymoquinone challenges UHRF1 to commit auto-ubiquitination: a key event for apoptosis induction in cancer cells. |
Q64063558 | UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells |
Q37105752 | UHRF1 gene silencing inhibits cell proliferation and promotes cell apoptosis in human cervical squamous cell carcinoma CaSki cells |
Q36587931 | UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy |
Q54330859 | UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer. |
Q36211327 | UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation |
Q91676720 | UHRF1 promotes renal cell carcinoma progression through epigenetic regulation of TXNIP |
Q37628934 | UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma |
Q36536562 | UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis |
Q64913033 | UHRF1 suppression promotes cell differentiation and reduces inflammatory reaction in anaplastic thyroid cancer. |
Q55333913 | WDR79 mediates the proliferation of non-small cell lung cancer cells by regulating the stability of UHRF1. |
Q37651410 | Zebrafish Discoveries in Cancer Epigenetics. |
Search more.